Liver cancer
Open
Phase 2
This trial is looking at giving pembrolizumab and lenvatinib before surgery for people with liver cancer.
It is open to people with a type of liver cancer called hepatocellular carcinoma.
Recruitment start: 28 August 2022
Recruitment end: 31 July 2026
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Tim Meyer
University College London (UCL)
Merck, Sharp & Dohme
Cancer Research UK & UCL Cancer Trials Centre
Last reviewed: 04 Aug 2024
CRUK internal database number: 18562
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
